MOACM
RCUS icon

Mutual of America Capital Management’s Arcus Biosciences RCUS Stock Holding History

Mutual of America Capital Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$210K Sell
9,701
-57
-0.6% -$1.23K ﹤0.01% 1297
2025
Q4 		$233K Buy
+9,758
New +$199K ﹤0.01% 1264
2023
Q3 		– Sell
-10,281
Closed -$209K – 1476
2023
Q2 		$209K Sell
10,281
-455
-4% -$8.66K ﹤0.01% 1395
2023
Q1 		$196K Sell
10,736
-191
-2% -$3.65K ﹤0.01% 1406
2022
Q4 		$226K Buy
10,927
+592
+6% +$16.3K ﹤0.01% 1358
2022
Q3 		$270K Buy
10,335
+2,505
+32% +$66.2K ﹤0.01% 1272
2022
Q2 		$198K Buy
+7,830
New +$192K ﹤0.01% 1333

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Mutual of America Capital Management's RCUS Position: Q1 2026 in Review

Mutual of America Capital Management reduced its Arcus Biosciences (RCUS) stake by 0.58% in Q1 2026, selling an estimated $1.23K and leaving 9,701 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #1297.

Mutual of America Capital Management first reported a position in RCUS in Q2 2022 and has held it in 7 quarters since. The position peaked at $270K in Q3 2022. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

  • Mutual of America Capital Management held 9,701 shares of Arcus Biosciences worth $210K as of Q1 2026.
  • Mutual of America Capital Management sold 57 Arcus Biosciences shares in Q1 2026, an estimated $1.23K.
  • Arcus Biosciences made up ﹤0.01% of Mutual of America Capital Management's portfolio in Q1 2026, its #1297 holding.
  • Mutual of America Capital Management first reported a position in Arcus Biosciences in Q2 2022 and has held it in 7 quarters since.
  • Mutual of America Capital Management's Arcus Biosciences position peaked at $270K in Q3 2022.
  • 210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Mutual of America Capital Management's 13F filing for Q1 2026, filed 7 May 2026.